Why Amarin Stock Dropped 19% in August
Shares of Irish biotech Amarin (NASDAQ: AMRN) fell 19.4% in August, according to data from S&P Global Market Intelligence. For context, the S&P 500, including dividends, edged down 1.6% last month.
Despite the August drop, Amarin stock -- which has climbed back 8.8% so far in September -- is still up a whopping 418% over the one-year period through Sept. 10, versus the broader market's 5.9% return over this period. That makes it one of the top-performing biotech stocks over the last year.
Image source: Getty Images.
Source Fool.com
